Visiongain has published a new report entitled Meningococcal Vaccines Market Report 2024-2034: Forecasts by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines), by Serogroups (A, B, C, Y, W-135 Vaccines, Serogroup B Vaccines), by Brands (Menactra, Menveo, Nimenrix, Bexsero, Trumenba), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVI
Global Meningococcal Vaccines Industry Thrives at 8 6% CAGR, Eyes Impressive US$ 7 7 Billion Milestone in 2032 | FMI fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
Meningococcal Vaccines Industry Analysis: Projected to Soar at 8 6% CAGR, Hitting US$ 7 7 Billion by 2032 | FMI fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
Over the forecast period, the market for Meningococcal Vaccines is anticipated to grow at a CAGR of 8.6%, reaching US$ 3.4 Bn in 2022. According to Future Market Insights (FMI), the conjugate vaccines segment held a 62.6% revenue share of the market in 2021.The global meningococcal vaccines market is expected to gro.
Fortifying Global Health: Meningococcal Vaccines Market Projected to Surge to US$ 7 7 Billion by 2032, Driven by Robust 8 6% CAGR Growth fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.